Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia
Click here to read the full press release: https://t.co/hVpJ0ZUMhO
My column from the DBAP tonight: @DukeBASE blew out Baylor for the second day in a row. It's early yet, but there are plenty of encouraging signs that the retooled Blue Devils are on track for a strong bounceback season:
https://t.co/HlZbRkzwPe
While we were busy tweeting about our offense, we almost forgot about freshman @owenproksch6. He made his Duke debut and it was a good one.
3 IP
0 R
1 H
4 K
1 BB